3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market


WASHINGTON, Oct. 09, 2022 (GLOBE NEWSWIRE) -- Global 3D bioprinting market was valued at USD 1.5 Billion in 2021 and is projected to attain a value of USD 3.7 Billion by 2028 during the forecast period, 2022–2028.

Get Sample Copy of This Report: https://www.vantagemarketresearch.com/3d-bioprinting-market-1235/request-sample

As the demand for bioprinting continues to increase, so too does the need for 3D bioprinting. 3D bioprinting market uses small droplets of cell-containing material to create 3D objects in vitro It is useful for creating organs, tissues, and other structures from stem cells or other cells. It is also useful for creating customized implants and drugs.

The growing demand for 3D bioprinting has led to the development of new technologies and processes that make it easier and faster to create 3D objects. As the technology opens up new opportunities for the development of novel medical treatments, 3D bioprinting market growth is being driven by the increasing demand for personalized medicine, as well as the increasing need for customized structures and therapies. With each passing year, the technology is also becoming more affordable and accessible, making it an attractive option for clinical applications. This growth in demand will likely continue to accelerate in the future, as further advances in technology are made.

Top Players in Global 3D Bioprinting Market

  • Envisiontec, Inc.
  • Organovo Holdings, Inc.
  • Inventia Life Science PTY LTD
  • Poietis
  • Vivax Bio
  • LLC
  • Allevi
  • Cyfuse Biomedical K.K.
  • 3D Bioprinting Solutions
  • Cellink Global
  • Regemat 3D S.L.

Bioprinting is booming as a technology for creating tissue and organ replacement parts. The following are three factors driving demand for this innovative technology:

1. Growing aging population: The world’s population is growing older, which means there will be an increasing need for tissue and organ replacements. Bioprinting can help to fill this need by creating replacement tissues and organs from patient-specific cells. Over 1 billion people are above 60 years old and the number is projected to expand to 1.4 billion by 2050.

2. Declining supplies of natural organs and tissues: The availability of natural organs and tissues for transplantation is dwindling in worldwide 3D bioprinting market due to the increasing incidence of diseases such as Alzheimer’s, heart failure, and cancer. By using bioprinting, hospitals can create replacement tissues or organs specifically tailored to the needs of individual patients.

3. Progress in regenerative medicine: Regenerative medicine utilizes techniques such as cell therapy and 3D printing to restore function to damaged or diseased tissue. By printing tissue components in a controlled environment, regenerative medicine providers are able to engineers complex tissue constructs that would otherwise be extremely difficult or impossible to achieve.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.vantagemarketresearch.com/buy-now/3d-bioprinting-market-1235/0

Key Findings:

  • The clinical sub-segment in applications segment is further categorized into skin printing, blood vessel printing, bone & cartilage printing, and others. In all these, skin printing is projected to grow during the forecast period. The growth is due to the technological advancements & new product launches coupled with an increasing number of aesthetic and reconstruction surgeries worldwide.
  • The living cells segment is expected to cover the largest market mainly due to heavy R&D in fields of regenerative medicine coupled with rising investments for supporting the research.
  • The factors driving the market growth is several advancements in tissue engineering that are being aimed at regeneration of damaged tissues as well as organs with the assistance of 3D bioprinting.

Scope of the Report:

Report AttributesDetails
Market Size in 2021USD 1.5 Billion
Revenue Forecast by 2028USD 3.7 Billion
CAGR20.2% from 2022 to 2028
Base Year2021 
Forecast Year2022 to 2028
Key Players
  • Envisiontec Inc.
  • Organovo Holdings Inc.
  • Inventia Life Science PTY LTD
  • Poietis
  • Vivax Bio
  • LLC
  • Allevi
  • Cyfuse Biomedical K.K.
  • 3D Bioprinting Solutions
  • Cellink Global
  • Regemat 3D S.L.

Increasing Adoption of 3D Bioprinting for Engineering Organs

3D bioprinting market is becoming an increasingly important as it enables the rapid, low-cost fabrication of complex components and structures from a variety of biocompatible materials. Vantage Market Research estimates that global spending on 3D printing services will top $2.3 billion by 2025, with growth rates well above the average for all software categories over the same period.

3D bioprinting market currently has niche applications in large-scale industrial production, but its potential to create low-cost human tissues and organs has drawn considerable interest. This is due in part to the high degree of customization that is possible with 3D bioprinting, which can enable precise control over tissue properties, including shape, size, and composition.

Every year, more than 10,000 Americans are put on waiting list for organ transplantation and over 6,000 of them die due to shortage or inability to get the suitable donor. This represents a huge opportunity for the players active in the global 3D bioprinting market to incentivize this revenue opportunity by engineering organ at scale to meet the demand and supply gap.

In fact, bioprinting is an emerging technology that enables the printing of nearly any type of biological tissue and organ. This technology has already been used to create structures such as heart valves, skin patches, and bone implants. However, there are still many applications for bioprinting that have yet to be explored.

3D printing is revolutionizing the way products are designed, and it is now being used to create organs at scale. By printing organs in a customized manner, we can improve the accuracy, predictability, and efficiency of organ printing.

There are many different types of organs that could benefit from bioprinting. Examples of organs that could be printed using this technology include lungs, liver, kidneys, and hearts. With bioprinting, surgeons could potentially print new organs onsite if they become damaged or diseased.

The applications for 3D bioprinting market are endless, and we are just starting to scratch the surface of what this technology can do. We believe that bioprinting will play a major role in engineering organ at scale in the future.

Download Full Report (176 Pages PDF with Insights, Charts, Tables, Figures) at@ https://www.vantagemarketresearch.com/industry-report/3d-bioprinting-market-1235

As per Vantage Market Research, end-users and scientist have started paying attention to making use of 3D bioprinting on large scale thanks to numerous benefits of using 3D bioprinting for organ engineering. Some of the most important benefits include:

  • Reduced costs – 3D bioprinting market is gaining momentum because the technology can save money by printing organs instead of acquiring them from donors.
  • Speed – 3D bioprinting can create organs much faster than traditional methods. This speed is important since it allows for faster patient timelines.
  • Durability – 3D bioprinted organs are more durable than traditional organ models. This makes them ideal for patients who are susceptible to infections or injuries.

Browse market data Tables and Figures spread through 176 Pages and in-depth TOC on "3d Bioprinting Market by Technology (Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based), by Application (Medical, Dental, Biosensors, Consumer/Personal Product Testing), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Inkjet Technology Generates More than 38% Revenue of Bioprinting Market

3D bioprinting market is becoming popular due to its versatility and ability to create complex tissue structures. However, one disadvantage of 3D bioprinting is the need for magnetic levitation technology in order to print large objects. Inkjet technology is becoming more popular for 3D bioprinting due to its lower printing costs and the ability to print larger objects. Inject technology uses a syringe filled with liquid bioprinters to create realistic tissue constructs.

Some of the biggest advantages of inkjet technology in the global 3D bioprinting market include its low cost and the ability to print complex tissue constructs. Inkjet printers can also produce large quantities of tissue at once, which makes them ideal for medical applications. Deploying inject printers in hospitals could improve the quality of patient care by allowing for faster production of customized tissue constructs. In addition, inject printers could help to reduce the cost of healthcare by reducing the need for magnetic levitation technology.

As per Vantage Market Research, most of the users in the global 3D bioprinting market prefer inkjet bioprinting technology because the printing can be faster and more accurate than magnetic levitation printing. Second, inkjet printing does not require the use of a cold bed or vacuum chamber – both of which can be time-consuming and expensive to set up. Third, inkjet printing is less likely to produce errors due to materials incompatibility than magnetic levitation printing. Inkjet printing is also better at reproducing delicate features and patterns than magnetic levitation printing.

Overall, inkjet technology is becoming more popular for 3D bioprinting due to its speed, accuracy, and versatility.

Key Questions Answered in The Report:

  • Which region will show the fastest and highest growth in the near future?
  • Which are the top five players and their weakness and strength of the Market?
  • What will be the future innovation in the upcoming six years?
  • Which application and product will lead the largest share of the Market?
  • What are the growth drivers, restraints and challenges of the industry?
  • What will be the CAGR and size of the 3D bioprinting Market for the base year and forecast period?

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Browse More Related Report:      

  • Neurostimulation Devices Market: Neurostimulation Devices Market was valued at USD 4.3 Billion in 2021 and is projected to reach a value of USD 8.7 Billion by 2028.                     
  • Mammography Market: Mammography Market was valued USD 1.8 Billion in 2021 and is anticipated to reach a value of USD 3.2 Billion by 2028. Over the projection timelines, the Global Market is forecasted to grow to exhibit a CAGR (Compound Annual Growth Rate) of 10.1%.       
  • Advanced Wound Care Market: Advanced Wound Care Market was valued at USD 9.1 Billion in 2021 and is forecast to reach a value of USD 12.8 Billion by 2028.
  • Orthopedic Implants Market: Orthopedic Implants Market was valued USD 42.1 Billion in 2021 and is anticipated to reach a value of USD 55.4 Billion by 2028. Over the projection period, the Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 4.7%.
  • Cannabidiol (CBD) Market: Cannabidiol (CBD) Market is valued at USD 4.9 Billion in 2021 and is projected to attain a value of USD 47.22 Billion by 2028 at a CAGR of 21.3% during the forecast period, 2022–2028.

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/

Follow Us on Twitter: https://twitter.com/vantagemarketr

Follow Us on Facebook: https://www.facebook.com/vantagemarketresearch

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs